Cefdinir
- Product NDC
- 68180-722
- 11-digit product format
- 681800722
- Labeler code
- 68180
- Product ID
- 68180-722_b32b7bfb-4770-4da0-8c48-684233cd10c9
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- Cefdinir
- Dosage form
- POWDER, FOR SUSPENSION
- Route
- ORAL
- Labeler
- Lupin Pharmaceuticals, Inc.
- Application
- ANDA065259
- Marketing category
- ANDA
- Marketing start
- 2006-05-31
- Substance
- CEFDINIR
- Active strength
- 125 mg/5mL
- Pharmacologic classes
- Cephalosporin Antibacterial [EPC], Cephalosporins [CS]
- NDC exclude flag
- No
- Listing certified through
- 2026-12-31
- Current FDA listing
- Yes
NDC auxiliary status#
These records are reproduced from FDA’s unfinished, excluded, and compounder listings. They describe what appeared in the source files; a missing record does not establish a regulatory status. View all current auxiliary records, including entries without an NDC. · View the auxiliary file history.
| Dataset | Scope | Product NDC | Package NDC | Code | Status | Reporting period | Source date |
|---|---|---|---|---|---|---|---|
| excluded package | package | 68180-722 | 68180-722-10 | D | Discontinued by firm | 2026-08-03 | |
| excluded package | package | 68180-722 | 68180-722-20 | D | Discontinued by firm | 2026-08-03 |
Observed NDC auxiliary status history#
This history shows the information present in each captured FDA auxiliary file. It is not a continuous regulatory timeline, and a missing record does not establish a status.
| Captured / source date | Package NDC | Snapshot | Source SHA-256 |
|---|---|---|---|
| 2025-12-14 17:58 UTC · source 2025-12-05 | 68180-722-20 | d630ba8d3edf… | 732f749b63fb… |
| 2025-12-14 17:58 UTC · source 2025-12-05 | 68180-722-10 | d630ba8d3edf… | 732f749b63fb… |
| 2025-08-27 00:01 UTC · source 2025-08-26 | 68180-722-20 | f5e01cc5f278… | a2eaf40c39c3… |
| 2025-08-27 00:01 UTC · source 2025-08-26 | 68180-722-10 | f5e01cc5f278… | a2eaf40c39c3… |
| 2025-04-01 02:39 UTC · source 2025-03-31 | 68180-722-20 | 2ef7874e63bc… | 57b86245f4fa… |
| 2025-04-01 02:39 UTC · source 2025-03-31 | 68180-722-10 | 2ef7874e63bc… | 57b86245f4fa… |
| 2025-03-28 20:22 UTC · source 2025-03-28 | 68180-722-20 | a1b67e2a42f9… | c4cf2c586c0d… |
| 2025-03-28 20:22 UTC · source 2025-03-28 | 68180-722-10 | a1b67e2a42f9… | c4cf2c586c0d… |
| 2025-03-22 03:12 UTC · source 2025-03-21 | 68180-722-20 | cfe11265f3b6… | 090c488252e2… |
| 2025-03-22 03:12 UTC · source 2025-03-21 | 68180-722-10 | cfe11265f3b6… | 090c488252e2… |
| 2025-03-10 12:48 UTC · source 2025-03-10 | 68180-722-20 | cdf11ea48f46… | ba0047e9e063… |
| 2025-03-10 12:48 UTC · source 2025-03-10 | 68180-722-10 | cdf11ea48f46… | ba0047e9e063… |
| 2025-02-02 03:52 UTC · source 2025-01-31 | 68180-722-20 | 302b2466d912… | e7b80fea0513… |
| 2025-02-02 03:52 UTC · source 2025-01-31 | 68180-722-10 | 302b2466d912… | e7b80fea0513… |
| 2025-01-20 13:05 UTC · source 2025-01-20 | 68180-722-20 | ed331223b511… | 672a5bd82f5f… |
| 2025-01-20 13:05 UTC · source 2025-01-20 | 68180-722-10 | ed331223b511… | 672a5bd82f5f… |
| 2025-01-11 03:41 UTC · source 2025-01-10 | 68180-722-20 | 0efc9e666f02… | f202fb6c5f17… |
| 2025-01-11 03:41 UTC · source 2025-01-10 | 68180-722-10 | 0efc9e666f02… | f202fb6c5f17… |
| 2024-11-09 02:27 UTC · source 2024-11-08 | 68180-722-20 | ad56d346431e… | cc804d4bbf1e… |
| 2024-11-09 02:27 UTC · source 2024-11-08 | 68180-722-10 | ad56d346431e… | cc804d4bbf1e… |
| 2024-10-04 04:10 UTC · source 2024-10-03 | 68180-722-20 | 367a005e9d99… | 383a685ebd0f… |
| 2024-10-04 04:10 UTC · source 2024-10-03 | 68180-722-10 | 367a005e9d99… | 383a685ebd0f… |
| 2024-07-10 04:00 UTC · source 2024-07-09 | 68180-722-20 | 557ba5c1ecfa… | 9c80585c8c6e… |
| 2024-07-10 04:00 UTC · source 2024-07-09 | 68180-722-10 | 557ba5c1ecfa… | 9c80585c8c6e… |
Orange Book products#
| Application-product | Trade name | Ingredient | Strength | Dosage form / route | TE codes | RLD / RS | Approval date |
|---|---|---|---|---|---|---|---|
| A065259-001 | CEFDINIR | CEFDINIR | 125MG/5ML | FOR SUSPENSION / ORAL | AB | 2006-05-31 | |
| A065259-002 | CEFDINIR | CEFDINIR | 250MG/5ML | FOR SUSPENSION / ORAL | AB | 2007-05-07 |
Therapeutic equivalence codes#
| Application-product | TE code |
|---|---|
| A065259-001 | AB |
| A065259-002 | AB |
Observed Orange Book product history#
Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.
| Captured | Edition | Application-product | Trade name | Strength | Dosage form / route | Product TE source text | RLD / RS | Approval date | Source SHA-256 |
|---|---|---|---|---|---|---|---|---|---|
| 2026-02-19 14:30 UTC | 2026-02 | A065259-001 | CEFDINIR | 125MG/5ML | FOR SUSPENSION / ORAL | AB | 2006-05-31 | 011fe1cb6892… | |
| 2026-02-19 14:30 UTC | 2026-02 | A065259-002 | CEFDINIR | 250MG/5ML | FOR SUSPENSION / ORAL | AB | 2007-05-07 | 011fe1cb6892… | |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | A065259-001 | CEFDINIR | 125MG/5ML | FOR SUSPENSION / ORAL | AB | 2006-05-31 | 31067a03dcf5… | |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | A065259-002 | CEFDINIR | 250MG/5ML | FOR SUSPENSION / ORAL | AB | 2007-05-07 | 31067a03dcf5… | |
| 2025-08-23 18:47 UTC | 2025-08 | A065259-001 | CEFDINIR | 125MG/5ML | FOR SUSPENSION / ORAL | AB | 2006-05-31 | 6a471c1ec25d… | |
| 2025-08-23 18:47 UTC | 2025-08 | A065259-002 | CEFDINIR | 250MG/5ML | FOR SUSPENSION / ORAL | AB | 2007-05-07 | 6a471c1ec25d… | |
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | A065259-001 | CEFDINIR | 125MG/5ML | FOR SUSPENSION / ORAL | AB | 2006-05-31 | fd3edfee7708… | |
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | A065259-002 | CEFDINIR | 250MG/5ML | FOR SUSPENSION / ORAL | AB | 2007-05-07 | fd3edfee7708… | |
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | A065259-001 | CEFDINIR | 125MG/5ML | FOR SUSPENSION / ORAL | AB | 2006-05-31 | b8a1b40f171c… | |
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | A065259-002 | CEFDINIR | 250MG/5ML | FOR SUSPENSION / ORAL | AB | 2007-05-07 | b8a1b40f171c… | |
| 2025-01-19 17:59 UTC · 7 captures of this ZIP | 2025-01 | A065259-001 | CEFDINIR | 125MG/5ML | FOR SUSPENSION / ORAL | AB | 2006-05-31 | 03ed91905a0d… | |
| 2025-01-19 17:59 UTC · 7 captures of this ZIP | 2025-01 | A065259-002 | CEFDINIR | 250MG/5ML | FOR SUSPENSION / ORAL | AB | 2007-05-07 | 03ed91905a0d… | |
| 2024-12-13 21:23 UTC · 2 captures of this ZIP | 2024-12 | A065259-001 | CEFDINIR | 125MG/5ML | FOR SUSPENSION / ORAL | AB | 2006-05-31 | 2680178bc6a6… | |
| 2024-12-13 21:23 UTC · 2 captures of this ZIP | 2024-12 | A065259-002 | CEFDINIR | 250MG/5ML | FOR SUSPENSION / ORAL | AB | 2007-05-07 | 2680178bc6a6… | |
| 2024-09-14 05:58 UTC · 2 captures of this ZIP | 2024-09 | A065259-001 | CEFDINIR | 125MG/5ML | FOR SUSPENSION / ORAL | AB | 2006-05-31 | 5bbf6a4d5a75… | |
| 2024-09-14 05:58 UTC · 2 captures of this ZIP | 2024-09 | A065259-002 | CEFDINIR | 250MG/5ML | FOR SUSPENSION / ORAL | AB | 2007-05-07 | 5bbf6a4d5a75… | |
| 2024-11-08 22:44 UTC · 3 captures of this ZIP | 2024-11 | A065259-001 | CEFDINIR | 125MG/5ML | FOR SUSPENSION / ORAL | AB | 2006-05-31 | d8e5a09893c0… | |
| 2024-11-08 22:44 UTC · 3 captures of this ZIP | 2024-11 | A065259-002 | CEFDINIR | 250MG/5ML | FOR SUSPENSION / ORAL | AB | 2007-05-07 | d8e5a09893c0… | |
| 2024-10-29 15:01 UTC | 2024-10 | A065259-001 | CEFDINIR | 125MG/5ML | FOR SUSPENSION / ORAL | AB | 2006-05-31 | d06236e962d9… | |
| 2024-10-29 15:01 UTC | 2024-10 | A065259-002 | CEFDINIR | 250MG/5ML | FOR SUSPENSION / ORAL | AB | 2007-05-07 | d06236e962d9… | |
| 2024-08-13 05:28 UTC · 3 captures of this ZIP | 2024-08 | A065259-001 | CEFDINIR | 125MG/5ML | FOR SUSPENSION / ORAL | AB | 2006-05-31 | 79d66fd596c7… | |
| 2024-08-13 05:28 UTC · 3 captures of this ZIP | 2024-08 | A065259-002 | CEFDINIR | 250MG/5ML | FOR SUSPENSION / ORAL | AB | 2007-05-07 | 79d66fd596c7… | |
| 2024-07-13 05:37 UTC · 2 captures of this ZIP | 2024-07 | A065259-001 | CEFDINIR | 125MG/5ML | FOR SUSPENSION / ORAL | AB | 2006-05-31 | 301d65b070ca… | |
| 2024-07-13 05:37 UTC · 2 captures of this ZIP | 2024-07 | A065259-002 | CEFDINIR | 250MG/5ML | FOR SUSPENSION / ORAL | AB | 2007-05-07 | 301d65b070ca… | |
| 2024-06-18 03:08 UTC · 5 captures of this ZIP | 2024-06 | A065259-001 | CEFDINIR | 125MG/5ML | FOR SUSPENSION / ORAL | AB | 2006-05-31 | 1e350fbaab3a… | |
| 2024-06-18 03:08 UTC · 5 captures of this ZIP | 2024-06 | A065259-002 | CEFDINIR | 250MG/5ML | FOR SUSPENSION / ORAL | AB | 2007-05-07 | 1e350fbaab3a… | |
| 2024-05-31 18:47 UTC | 2024-05 | A065259-001 | CEFDINIR | 125MG/5ML | FOR SUSPENSION / ORAL | AB | 2006-05-31 | 8072bd15b7f6… | |
| 2024-05-31 18:47 UTC | 2024-05 | A065259-002 | CEFDINIR | 250MG/5ML | FOR SUSPENSION / ORAL | AB | 2007-05-07 | 8072bd15b7f6… | |
| 2022-06-29 02:47 UTC · 2 captures of this ZIP | 2022-06 | A065259-001 | CEFDINIR | 125MG/5ML | FOR SUSPENSION / ORAL | AB | 2006-05-31 | 5c6f7cd8ea54… | |
| 2022-06-29 02:47 UTC · 2 captures of this ZIP | 2022-06 | A065259-002 | CEFDINIR | 250MG/5ML | FOR SUSPENSION / ORAL | AB | 2007-05-07 | 5c6f7cd8ea54… | |
| 2022-04-08 23:34 UTC | 2022-04 | A065259-001 | CEFDINIR | 125MG/5ML | FOR SUSPENSION / ORAL | AB | 2006-05-31 | 5d02ea3f76ae… | |
| 2022-04-08 23:34 UTC | 2022-04 | A065259-002 | CEFDINIR | 250MG/5ML | FOR SUSPENSION / ORAL | AB | 2007-05-07 | 5d02ea3f76ae… | |
| 2022-04-04 05:41 UTC | 2022-04 | A065259-001 | CEFDINIR | 125MG/5ML | FOR SUSPENSION / ORAL | AB | 2006-05-31 | 4b0b4de00fa7… | |
| 2022-04-04 05:41 UTC | 2022-04 | A065259-002 | CEFDINIR | 250MG/5ML | FOR SUSPENSION / ORAL | AB | 2007-05-07 | 4b0b4de00fa7… | |
| 2019-12-13 00:20 UTC | 2019-12 | A065259-001 | CEFDINIR | 125MG/5ML | FOR SUSPENSION / ORAL | AB | 2006-05-31 | 74a2ff9319b5… | |
| 2019-12-13 00:20 UTC | 2019-12 | A065259-002 | CEFDINIR | 250MG/5ML | FOR SUSPENSION / ORAL | AB | 2007-05-07 | 74a2ff9319b5… | |
| 2022-03-09 01:35 UTC | 2022-03 | A065259-001 | CEFDINIR | 125MG/5ML | FOR SUSPENSION / ORAL | AB | 2006-05-31 | bb7c543d1eb4… | |
| 2022-03-09 01:35 UTC | 2022-03 | A065259-002 | CEFDINIR | 250MG/5ML | FOR SUSPENSION / ORAL | AB | 2007-05-07 | bb7c543d1eb4… | |
| 2021-12-28 21:50 UTC | 2021-12 | A065259-001 | CEFDINIR | 125MG/5ML | FOR SUSPENSION / ORAL | AB | 2006-05-31 | 782e0a99824c… | |
| 2021-12-28 21:50 UTC | 2021-12 | A065259-002 | CEFDINIR | 250MG/5ML | FOR SUSPENSION / ORAL | AB | 2007-05-07 | 782e0a99824c… |
Observed Orange Book normalized TE history#
| Captured | Edition | Application-product | TE code | Order | Source SHA-256 |
|---|---|---|---|---|---|
| 2026-02-19 14:30 UTC | 2026-02 | A065259-001 | AB | 1 | 011fe1cb6892… |
| 2026-02-19 14:30 UTC | 2026-02 | A065259-002 | AB | 1 | 011fe1cb6892… |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | A065259-001 | AB | 1 | 31067a03dcf5… |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | A065259-002 | AB | 1 | 31067a03dcf5… |
| 2025-08-23 18:47 UTC | 2025-08 | A065259-001 | AB | 1 | 6a471c1ec25d… |
| 2025-08-23 18:47 UTC | 2025-08 | A065259-002 | AB | 1 | 6a471c1ec25d… |
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | A065259-001 | AB | 1 | fd3edfee7708… |
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | A065259-002 | AB | 1 | fd3edfee7708… |
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | A065259-001 | AB | 1 | b8a1b40f171c… |
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | A065259-002 | AB | 1 | b8a1b40f171c… |
| 2025-01-19 17:59 UTC · 7 captures of this ZIP | 2025-01 | A065259-001 | AB | 1 | 03ed91905a0d… |
| 2025-01-19 17:59 UTC · 7 captures of this ZIP | 2025-01 | A065259-002 | AB | 1 | 03ed91905a0d… |
| 2024-12-13 21:23 UTC · 2 captures of this ZIP | 2024-12 | A065259-001 | AB | 1 | 2680178bc6a6… |
| 2024-12-13 21:23 UTC · 2 captures of this ZIP | 2024-12 | A065259-002 | AB | 1 | 2680178bc6a6… |
| 2024-09-14 05:58 UTC · 2 captures of this ZIP | 2024-09 | A065259-001 | AB | 1 | 5bbf6a4d5a75… |
| 2024-09-14 05:58 UTC · 2 captures of this ZIP | 2024-09 | A065259-002 | AB | 1 | 5bbf6a4d5a75… |
| 2024-11-08 22:44 UTC · 3 captures of this ZIP | 2024-11 | A065259-001 | AB | 1 | d8e5a09893c0… |
| 2024-11-08 22:44 UTC · 3 captures of this ZIP | 2024-11 | A065259-002 | AB | 1 | d8e5a09893c0… |
| 2024-10-29 15:01 UTC | 2024-10 | A065259-001 | AB | 1 | d06236e962d9… |
| 2024-10-29 15:01 UTC | 2024-10 | A065259-002 | AB | 1 | d06236e962d9… |
| 2024-08-13 05:28 UTC · 3 captures of this ZIP | 2024-08 | A065259-001 | AB | 1 | 79d66fd596c7… |
| 2024-08-13 05:28 UTC · 3 captures of this ZIP | 2024-08 | A065259-002 | AB | 1 | 79d66fd596c7… |
| 2024-07-13 05:37 UTC · 2 captures of this ZIP | 2024-07 | A065259-001 | AB | 1 | 301d65b070ca… |
| 2024-07-13 05:37 UTC · 2 captures of this ZIP | 2024-07 | A065259-002 | AB | 1 | 301d65b070ca… |
| 2024-06-18 03:08 UTC · 5 captures of this ZIP | 2024-06 | A065259-001 | AB | 1 | 1e350fbaab3a… |
| 2024-06-18 03:08 UTC · 5 captures of this ZIP | 2024-06 | A065259-002 | AB | 1 | 1e350fbaab3a… |
| 2024-05-31 18:47 UTC | 2024-05 | A065259-001 | AB | 1 | 8072bd15b7f6… |
| 2024-05-31 18:47 UTC | 2024-05 | A065259-002 | AB | 1 | 8072bd15b7f6… |
| 2022-06-29 02:47 UTC · 2 captures of this ZIP | 2022-06 | A065259-001 | AB | 1 | 5c6f7cd8ea54… |
| 2022-06-29 02:47 UTC · 2 captures of this ZIP | 2022-06 | A065259-002 | AB | 1 | 5c6f7cd8ea54… |
| 2022-04-08 23:34 UTC | 2022-04 | A065259-001 | AB | 1 | 5d02ea3f76ae… |
| 2022-04-08 23:34 UTC | 2022-04 | A065259-002 | AB | 1 | 5d02ea3f76ae… |
| 2022-04-04 05:41 UTC | 2022-04 | A065259-001 | AB | 1 | 4b0b4de00fa7… |
| 2022-04-04 05:41 UTC | 2022-04 | A065259-002 | AB | 1 | 4b0b4de00fa7… |
| 2019-12-13 00:20 UTC | 2019-12 | A065259-001 | AB | 1 | 74a2ff9319b5… |
| 2019-12-13 00:20 UTC | 2019-12 | A065259-002 | AB | 1 | 74a2ff9319b5… |
| 2022-03-09 01:35 UTC | 2022-03 | A065259-001 | AB | 1 | bb7c543d1eb4… |
| 2022-03-09 01:35 UTC | 2022-03 | A065259-002 | AB | 1 | bb7c543d1eb4… |
| 2021-12-28 21:50 UTC | 2021-12 | A065259-001 | AB | 1 | 782e0a99824c… |
| 2021-12-28 21:50 UTC | 2021-12 | A065259-002 | AB | 1 | 782e0a99824c… |
Additional Listing Data#
- Finished product
- Yes
- Brand name base
- Cefdinir
- Listing expiration
- 2026-12-31
Active Ingredients#
| Ingredient | Strength |
|---|---|
| CEFDINIR | 125 mg/5mL |
Harmonized UNII identifiers#
| Identifier | FDA.report destination |
|---|---|
| CI0FAO63WC | Internal UNII lookup |
Harmonized RxCUI identifiers#
Harmonized SPL set identifiers#
| Identifier | FDA.report destination |
|---|---|
| 7490df67-56c0-4a1c-8533-2107f3e8aea5 | Available on FDA.report |
DailyMed Product Concepts#
| Product concept | Relation | Version | Effective |
|---|---|---|---|
| e2db08c6-133f-4f4f-afb4-e90a2418d6f6 | Product name | 1 | 20230320 |
| c6f86816-7da6-43ea-8c25-ac9758311cc5 | Product name | 1 | 20220118 |
| d3e72f63-2c41-955f-f4ce-e90c6403e67c | Product name | 2 | 20210729 |
| e8e66e64-d220-99cb-44eb-0f32dc8cbda1 | Product name | 2 | 20210729 |
| ce6d5c06-3ae0-18a6-d5b3-8cd3cc0f8906 | Product name | 7 | 20210625 |
| f52be47f-7aa7-46c0-b1fa-50c18dd50206 | Product name | 1 | 20201029 |
| 11ed6f83-cdd2-4637-8379-b1a1d3ae3cde | Product name | 1 | 20181101 |
| 86c45a79-b9f0-4476-a27c-6e10db098497 | Product name | 1 | 20180125 |
| 252e11b6-1a9a-4283-a242-df2c129c496d | Product name | 3 | 20170717 |
| d5e51f11-ad28-caa4-4b49-4143974782ad | Product name | 1 | 20150831 |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 68180-722-04 | Cefdinir | 60 mL in 1 BOTTLE | POWDER, FOR SUSPENSION | 60 | 9 | |
| 68180-722-05 | Cefdinir | 100 mL in 1 BOTTLE | POWDER, FOR SUSPENSION | 100 | 9 | |
| 68180-722-10 | Cefdinir | 100 mL in 1 BOTTLE | POWDER, FOR SUSPENSION | 100 | 9 | |
| 68180-722-20 | Cefdinir | 60 mL in 1 BOTTLE | POWDER, FOR SUSPENSION | 60 | 9 |
DailyMed Billing Units#
| Package NDC | Billing unit | Product NDC | DailyMed indexing SPL | SPL version | Effective |
|---|---|---|---|---|---|
| 68180-722-04 | ML - Milliliter | 68180-722 | 01bf7635-5944-4fa7-900c-4d7fc25dd816 | 1 | 2020-09-14 |
| 68180-722-05 | ML - Milliliter | 68180-722 | f7744bad-7050-4c75-b896-a69722118ba7 | 1 | 2020-09-14 |
| 68180-722-10 | ML - Milliliter | 68180-722 | e112b44c-4952-4e19-91a3-513814f221c4 | 1 | 2012-07-24 |
| 68180-722-20 | ML - Milliliter | 68180-722 | 54421622-3215-4eec-b70e-824d5d56ef3e | 1 | 2012-07-24 |
DailyMed Socrata Ingredients#
DailyMed Dashboard NDC Coverage#
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Cefdinir | CEFDINIR | Preferred Pharmaceuticals Inc. | 3714d558-cbaa-42e8-831b-ffbbc951ebf2 | 2026-04-21 | Warnings | 065259 ANDA065259 |
| Cefdinir | CEFDINIR | A-S Medication Solutions | 17b4e82f-4169-4ab9-bd4a-79781a71e160 | 2025-12-19 | Warnings | 065259 ANDA065259 |
| Cefdinir | CEFDINIR | Lupin Pharmaceuticals, Inc. | 7490df67-56c0-4a1c-8533-2107f3e8aea5 | 2025-09-23 | Warnings | 065259 ANDA065259 68180-722 |
| Cefdinir | CEFDINIR | Asclemed USA, Inc. | e90660c8-2714-4592-aeaa-bc9ceb26057c | 2025-04-19 | Warnings | 065259 ANDA065259 |
| Cefdinir | CEFDINIR | NuCare Pharmaceuticals, Inc. | 2fb43fbe-2c4b-1df9-e063-6394a90a9913 | 2025-03-06 | Warnings | 065259 ANDA065259 |
| Cefdinir | CEFDINIR | NuCare Pharmaceuticals,Inc. | fbd76f8c-e6b8-52f4-e053-6394a90aa7ab | 2025-02-04 | Warnings | 065259 ANDA065259 |
| CEFDINIR | CEFDINIR | DIRECT RX | 982d0f53-20bc-1cb4-e053-2995a90ad33c | 2025-01-22 | Warnings | 065259 ANDA065259 |
| Cefdinir | CEFDINIR | NuCare Pharmaceuticals,Inc. | 1bbd75ea-5a50-eb00-e063-6394a90a1cec | 2024-06-25 | Warnings | 065259 ANDA065259 |
| Cefdinir | CEFDINIR | A-S Medication Solutions | 37b5d000-db9e-4b6e-8208-6361e98fb55d | 2023-11-01 | Warnings | 065259 ANDA065259 |
| Cefdinir | CEFDINIR | Proficient Rx LP | 444cd2c4-836d-40d5-a307-d719fe83e763 | 2022-05-02 | Warnings | 065259 ANDA065259 |
DailyMed RxNorm Mappings#
| RxCUI | RxNorm string | TTY | DailyMed | SPL version |
|---|---|---|---|---|
| 309054 | cefdinir 125 MG in 5 mL Oral Suspension | PSN | 7490df67-56c0-4a1c-8533-2107f3e8aea5 | 9 |
| 476576 | cefdinir 250 MG in 5 mL Oral Suspension | PSN | 7490df67-56c0-4a1c-8533-2107f3e8aea5 | 9 |
| 309054 | cefdinir 25 MG/ML Oral Suspension | SCD | 7490df67-56c0-4a1c-8533-2107f3e8aea5 | 9 |
| 476576 | cefdinir 50 MG/ML Oral Suspension | SCD | 7490df67-56c0-4a1c-8533-2107f3e8aea5 | 9 |
| 309054 | cefdinir 125 MG per 5 ML Oral Suspension | SY | 7490df67-56c0-4a1c-8533-2107f3e8aea5 | 9 |
| 476576 | cefdinir 250 MG per 5 ML Oral Suspension | SY | 7490df67-56c0-4a1c-8533-2107f3e8aea5 | 9 |
| 309054 | cefdinir 125 MG in 5 mL Oral Suspension | PSN | e90660c8-2714-4592-aeaa-bc9ceb26057c | 1 |
| 309054 | cefdinir 125 MG in 5 mL Oral Suspension | PSN | 1bbd75ea-5a50-eb00-e063-6394a90a1cec | 1 |
| 309054 | cefdinir 125 MG in 5 mL Oral Suspension | PSN | 92c0f898-1f5d-c28e-e053-2995a90a9d66 | 1 |
| 309054 | cefdinir 125 MG in 5 mL Oral Suspension | PSN | 2fb43fbe-2c4b-1df9-e063-6394a90a9913 | 1 |
| 476576 | cefdinir 250 MG in 5 mL Oral Suspension | PSN | e90660c8-2714-4592-aeaa-bc9ceb26057c | 1 |
| 309054 | cefdinir 25 MG/ML Oral Suspension | SCD | 2fb43fbe-2c4b-1df9-e063-6394a90a9913 | 1 |
| 309054 | cefdinir 25 MG/ML Oral Suspension | SCD | 92c0f898-1f5d-c28e-e053-2995a90a9d66 | 1 |
| 309054 | cefdinir 25 MG/ML Oral Suspension | SCD | e90660c8-2714-4592-aeaa-bc9ceb26057c | 1 |
| 309054 | cefdinir 25 MG/ML Oral Suspension | SCD | 1bbd75ea-5a50-eb00-e063-6394a90a1cec | 1 |
| 476576 | cefdinir 50 MG/ML Oral Suspension | SCD | e90660c8-2714-4592-aeaa-bc9ceb26057c | 1 |
| 309054 | cefdinir 125 MG per 5 ML Oral Suspension | SY | 2fb43fbe-2c4b-1df9-e063-6394a90a9913 | 1 |
| 309054 | cefdinir 125 MG per 5 ML Oral Suspension | SY | 92c0f898-1f5d-c28e-e053-2995a90a9d66 | 1 |
| 309054 | cefdinir 125 MG per 5 ML Oral Suspension | SY | 1bbd75ea-5a50-eb00-e063-6394a90a1cec | 1 |
| 309054 | cefdinir 125 MG per 5 ML Oral Suspension | SY | e90660c8-2714-4592-aeaa-bc9ceb26057c | 1 |
| 476576 | cefdinir 250 MG per 5 ML Oral Suspension | SY | e90660c8-2714-4592-aeaa-bc9ceb26057c | 1 |
Packages#
| Package NDC | 11-digit format | Description | Units | Marketing start | Marketing end | Sample | Exclude flag | Status |
|---|---|---|---|---|---|---|---|---|
| 68180-722-04 | 68180072204 | 60 mL in 1 BOTTLE (68180-722-04) | 60 ml | 2020-05-22 | 0000-00-00 | No | No | Current |
| 68180-722-05 | 68180072205 | 100 mL in 1 BOTTLE (68180-722-05) | 100 ml | 2020-05-22 | 0000-00-00 | No | No | Current |
| 68180-722-10 | 68180072210 | 100 mL in 1 BOTTLE (68180-722-10) | 100 ml | 2006-05-31 | 2022-01-31 | No | No | Current |
| 68180-722-20 | 68180072220 | 60 mL in 1 BOTTLE (68180-722-20) | 60 ml | 2007-05-07 | 2022-01-31 | No | No | Current |